GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Northwest Biotherapeutics Inc (LTS:0K95) » Definitions » E10

Northwest Biotherapeutics (LTS:0K95) E10 : £-3.19 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Northwest Biotherapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Northwest Biotherapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was £-0.016. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is £-3.19 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 28.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Northwest Biotherapeutics was 50.80% per year. The lowest was 21.60% per year. And the median was 29.30% per year.

As of today (2024-06-23), Northwest Biotherapeutics's current stock price is £2.40. Northwest Biotherapeutics's E10 for the quarter that ended in Mar. 2024 was £-3.19. Northwest Biotherapeutics's Shiller PE Ratio of today is .


Northwest Biotherapeutics E10 Historical Data

The historical data trend for Northwest Biotherapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Northwest Biotherapeutics E10 Chart

Northwest Biotherapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.26 -3.43 -5.38 -3.15 -2.74

Northwest Biotherapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.76 -3.97 -2.27 -2.74 -3.19

Competitive Comparison of Northwest Biotherapeutics's E10

For the Biotechnology subindustry, Northwest Biotherapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Northwest Biotherapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Northwest Biotherapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Northwest Biotherapeutics's Shiller PE Ratio falls into.



Northwest Biotherapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Northwest Biotherapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.016/131.7762*131.7762
=-0.016

Current CPI (Mar. 2024) = 131.7762.

Northwest Biotherapeutics Quarterly Data

per share eps CPI Adj_EPS
201406 -0.266 100.560 -0.349
201409 -0.215 100.428 -0.282
201412 -0.415 99.070 -0.552
201503 -0.448 99.621 -0.593
201506 -0.565 100.684 -0.739
201509 0.163 100.392 0.214
201512 -0.174 99.792 -0.230
201603 -0.042 100.470 -0.055
201606 -0.113 101.688 -0.146
201609 -0.213 101.861 -0.276
201612 -0.200 101.863 -0.259
201703 -0.065 102.862 -0.083
201706 -0.039 103.349 -0.050
201709 -0.060 104.136 -0.076
201712 -0.075 104.011 -0.095
201803 -0.064 105.290 -0.080
201806 -0.045 106.317 -0.056
201809 0.015 106.507 0.019
201812 0.000 105.998 0.000
201903 -0.030 107.251 -0.037
201906 0.000 108.070 0.000
201909 -0.008 108.329 -0.010
201912 0.008 108.420 0.010
202003 0.003 108.902 0.004
202006 -0.064 108.767 -0.078
202009 -0.201 109.815 -0.241
202012 -0.275 109.897 -0.330
202103 -0.004 111.754 -0.005
202106 -0.007 114.631 -0.008
202109 -0.007 115.734 -0.008
202112 -0.015 117.630 -0.017
202203 -0.008 121.301 -0.009
202206 -0.008 125.017 -0.008
202209 -0.026 125.227 -0.027
202212 -0.016 125.222 -0.017
202303 -0.008 127.348 -0.008
202306 -0.008 128.729 -0.008
202309 -0.016 129.860 -0.016
202312 -0.016 129.419 -0.016
202403 -0.016 131.776 -0.016

Add all the adjusted EPS together and divide 10 will get our e10.


Northwest Biotherapeutics  (LTS:0K95) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Northwest Biotherapeutics E10 Related Terms

Thank you for viewing the detailed overview of Northwest Biotherapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Northwest Biotherapeutics (LTS:0K95) Business Description

Traded in Other Exchanges
Address
4800 Montgomery Lane, Suite 800, Bethesda, MD, USA, 20814
Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S. Food and Drug Administration.

Northwest Biotherapeutics (LTS:0K95) Headlines

No Headlines